{"id":"https://openalex.org/W2326004232","doi":"https://doi.org/10.1097/00000421-200102000-00011","title":"Lack of Efficacy of Topotecan in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Head and Neck","display_name":"Lack of Efficacy of Topotecan in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Head and Neck","publication_year":2001,"publication_date":"2001-02-01","ids":{"openalex":"https://openalex.org/W2326004232","doi":"https://doi.org/10.1097/00000421-200102000-00011","mag":"2326004232","pmid":"https://pubmed.ncbi.nlm.nih.gov/11232952"},"language":"en","primary_location":{"id":"doi:10.1097/00000421-200102000-00011","doi":"https://doi.org/10.1097/00000421-200102000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00000421-200102000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology: Cancer Clinical Trials","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048060803","display_name":"Barbara A. Murphy","orcid":"https://orcid.org/0000-0002-6376-6180","observed_orcids":["https://orcid.org/0000-0002-6376-6180","https://orcid.org/0000-0002-9242-9810"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Barbara A. Murphy","raw_affiliation_strings":["Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA","Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","institution_ids":[]},{"raw_affiliation_string":"Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210150714"]},{"raw_affiliation_string":"This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018311470","display_name":"Traci L. Leong","orcid":"https://orcid.org/0000-0003-2347-4260","observed_orcids":["https://orcid.org/0000-0003-2347-4260"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Traci Leong","raw_affiliation_strings":["Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]},{"raw_affiliation_string":"Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","institution_ids":[]},{"raw_affiliation_string":"Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210150714"]},{"raw_affiliation_string":"This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017367541","display_name":"Brian B. Burkey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Burkey","raw_affiliation_strings":["Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]},{"raw_affiliation_string":"Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","institution_ids":[]},{"raw_affiliation_string":"Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210150714"]},{"raw_affiliation_string":"This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090256464","display_name":"Corey Jay Langer","orcid":"https://orcid.org/0000-0002-8483-6811","observed_orcids":["https://orcid.org/0000-0002-8483-6811"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey Langer","raw_affiliation_strings":["Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]},{"raw_affiliation_string":"Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","institution_ids":[]},{"raw_affiliation_string":"Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210150714"]},{"raw_affiliation_string":"This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058886644","display_name":"A A Forastiere","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"and Arlene Forastiere","raw_affiliation_strings":["Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute (T.L.), Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Fox Chase Cancer Center (C.L.), Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, Department of Medicine, Vanderbilt University (B.A.M., B.B.), Nashville, Tennessee","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"and Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]},{"raw_affiliation_string":"Contents herein are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute","institution_ids":[]},{"raw_affiliation_string":"Johns Hopkins Oncology Center (A.F.), Baltimore, Maryland, U.S.A","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210150714"]},{"raw_affiliation_string":"This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Services grants CA 49957, CA 16116, CA 21115 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5048060803"],"corresponding_institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I145311948","https://openalex.org/I200719446","https://openalex.org/I2799853436","https://openalex.org/I4210117453","https://openalex.org/I4210140884","https://openalex.org/I4210150714"],"apc_list":null,"apc_paid":null,"fwci":0.7433,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.74403005,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"24","issue":"1","first_page":"64","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":1.0},{"id":"https://openalex.org/keywords/metastatic-head-and-neck-cancer","display_name":"metastatic head and neck cancer","score":0.8790000081062317},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.9369999766349792},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7889999747276306},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.8370000123977661},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9665644764900208},{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.9258836507797241},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6605372428894043},{"id":"https://openalex.org/C2994491419","wikidata":"https://www.wikidata.org/wiki/Q681817","display_name":"Squamous carcinoma","level":3,"score":0.6201845407485962},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5564692616462708},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.498668909072876},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4684968590736389},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44613224267959595},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.42110005021095276}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00000421-200102000-00011","doi":"https://doi.org/10.1097/00000421-200102000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00000421-200102000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology: Cancer Clinical Trials","raw_type":"journal-article"},{"id":"pmid:11232952","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11232952","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G3210846400","display_name":null,"funder_award_id":"CA49957","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3704097003","display_name":"Eastern Cooperative Oncology Group","funder_award_id":"U10CA016116","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5765316850","display_name":null,"funder_award_id":"CA-16116","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7219782544","display_name":"Eastern Cooperative Oncology Group","funder_award_id":"U10CA049957","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8181418271","display_name":"Eastern Cooperative Oncology Group Operations Office","funder_award_id":"U10CA021115","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G964706321","display_name":null,"funder_award_id":"CA 21115","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W119354384","https://openalex.org/W1979300931","https://openalex.org/W1991355508","https://openalex.org/W2034706703","https://openalex.org/W2054486764","https://openalex.org/W2277082935","https://openalex.org/W2323954108","https://openalex.org/W2412846321","https://openalex.org/W2416446439","https://openalex.org/W3041047318"],"related_works":["https://openalex.org/W2323954108","https://openalex.org/W2034706703","https://openalex.org/W2108213080","https://openalex.org/W2055537489","https://openalex.org/W2063824814","https://openalex.org/W174625399","https://openalex.org/W83619925","https://openalex.org/W1912598492","https://openalex.org/W2789606509","https://openalex.org/W2006876985"],"abstract_inverted_index":{"Recurrent":[0],"or":[1,84],"metastatic":[2,83],"squamous":[3,47,87],"carcinoma":[4,48,88],"of":[5,33,49,64,72,89,113,148,185],"the":[6,31,50,68,90],"head":[7,51,91],"and":[8,52,70,92,111,124,129,141,146,167],"neck":[9,93],"(RMSCHN)":[10],"is":[11,37,188],"a":[12,38,60,73],"modestly":[13],"chemoresponsive":[14],"tumor;":[15],"however,":[16],"currently":[17],"available":[18],"agents":[19,27],"have":[20],"failed":[21,175],"to":[22,66,176],"improve":[23],"survival.":[24],"New":[25],"active":[26],"are":[28],"needed":[29],"for":[30,160,170],"treatment":[32,75],"this":[34,186],"disease.":[35],"Topotecan":[36,174],"topoisomerase":[39],"inhibitor":[40],"that":[41],"demonstrated":[42],"initial":[43],"promising":[44],"activity":[45],"in":[46,77,120,144,155,179],"neck.":[53],"The":[54],"Eastern":[55],"Cooperative":[56],"Oncology":[57],"Group":[58],"conducted":[59],"phase":[61],"II":[62],"trial":[63],"topotecan":[65,97],"determine":[67],"efficacy":[69,178],"toxicity":[71],"weekly":[74],"schedule":[76],"patients":[78,133,163,180],"with":[79,82,96,181],"RMSCHN.":[80,182],"Patients":[81,117],"locally":[85],"recurrent":[86],"were":[94,118,134,153],"treated":[95,132,172],"1.5":[98],"mg/m2":[99],"x":[100],"24":[101],"hours":[102],"by":[103],"continuous":[104],"infusion":[105],"on":[106,136],"days":[107],"1,":[108],"8,":[109],"15,":[110],"22":[112],"each":[114],"35-day":[115],"cycle.":[116],"stratified":[119],"two":[121],"cohorts:":[122],"chemonaive":[123,128],"previously":[125,131,161,171],"treated.":[126],"Sixteen":[127],"16":[130],"registered":[135],"study.":[137],"Grade":[138],"III/IV":[139],"neutropenia":[140],"anemia":[142],"occurred":[143],"16%":[145],"18%":[147],"patients,":[149],"respectively.":[150],"No":[151],"responses":[152],"observed":[154],"either":[156],"cohort.":[157],"Median":[158],"survival":[159],"untreated":[162],"was":[164],"4.6":[165],"months":[166,169],"3.2":[168],"patients.":[173],"demonstrate":[177],"Further":[183],"evaluation":[184],"agent":[187],"not":[189],"planned.":[190]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}